NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 148 filers reported holding NOVAVAX INC in Q1 2019. The put-call ratio across all filers is 1.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,000 | -75.0% | 252 | -87.9% | 0.00% | – |
| Q4 2018 | $4,000 | +100.0% | 2,078 | +97.7% | 0.00% | – |
| Q1 2018 | $2,000 | +100.0% | 1,051 | +32.2% | 0.00% | – |
| Q4 2017 | $1,000 | -75.0% | 795 | -75.8% | 0.00% | – |
| Q3 2017 | $4,000 | -20.0% | 3,279 | -26.7% | 0.00% | – |
| Q2 2017 | $5,000 | -16.7% | 4,474 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $6,000 | 0.0% | 4,474 | -13.2% | 0.00% | 0.0% |
| Q4 2016 | $6,000 | – | 5,153 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caption Management, LLC | 2,021,600 | $22,273,000 | 1.23% |
| GREAT POINT PARTNERS LLC | 4,500,000 | $2,479,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 860,000 | $474,000 | 0.23% |
| Sargent Investment Group, LLC | 588,070 | $324,000 | 0.16% |
| BB BIOTECH AG | 8,330,000 | $4,589,000 | 0.12% |
| GREAT POINT PARTNERS LLC | 2,000,000 | $1,102,000 | 0.11% |
| CENTAURUS FINANCIAL, INC. | 7 | $12,000,000 | 0.07% |
| Rock Springs Capital Management LP | 3,250,000 | $1,790,000 | 0.07% |
| Beirne Wealth Consulting Services, LLC | 155,000 | $85,000 | 0.07% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $138,000 | 0.07% |